Table 5.

CC₅₀ Values of Selected Compounds (7c, 7e, 7f, 7g, 7i, 7j, 7l, 7o, 7q, 7r) and Standard Drugs (SAHA, Pioglitazone) ^a

compounds	cell line	CC50 (μM)	SCI
7c	CEM	2.8 ± 0.31	14.4
	Ramos	7.0 ± 1.17	5.8
	HeLa	10.3 ± 0.56	3.9
	SH-SY5Y	49.5 ± 1.09	0.8
	HS-27	40.2 ± 4.75	-
7e	Ramos	6.2 ± 0.28	>10
7f	CEM	10.6 ± 0.22	>10
	Ramos	9.1 ± 0.08	>10
7g	CEM	10.7 ± 0.41	>10
	Ramos	9.3 ± 0.01	>10
	HeLa	10.4 ± 0.58	>10
	MDA-MB-231	9.8 ± 0.22	>10
7i	CEM	9.6 ± 0.15	4.2
	Ramos	9.6 ± 0.14	4.2
	HeLa	10.4 ± 0.16	3.8
	MDA-MB-231	9.8 ± 0.1	4.1
	SH-SY5Y	21.8 ± 0.41	1.8
	HS-27	39.9 ± 1.95	-
7j	Ramos	10.0 ± 0.39	>10
	HeLa	10.2 ± 0.52	>10
	MDA-MB-231	10.3 ± 0.12	>10
	SH-SY5Y	52.3 ± 3.09	>10
7l	HeLa	9.9 ± 0.25	>10
	SH-SY5Y	91.1 ± 4.26	>10
7o	HeLa	10.1 ± 0.04	>10
7q	MDA-MB-231	55.8 ± 1.56	>10
7r	CEM	40.9 ± 3.16	1.4
	SH-SY5Y	16.0 ± 0.69	3.6
	HS-27	57.0 ± 8.45	-
Pioglitazone	CEM	0% @ 50 μM	-
	HeLa	0% @ 10 μM	-
SAHA	CEM	2.5 ± 0.13	-
	HeLa	2.8 ± 1.47	-

^aCC₅₀ reported as average concentration ± std. deviation (μM); SCI = CC_50HS‑27/CC_50cancer; Nd*-Not determined